Published in Nature on July 27, 1978
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest (2000) 3.15
T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci U S A (1991) 1.49
IgA antibodies in the bile of rats. I. Some characteristics of the primary response. Immunology (1982) 1.46
A reproducible brain tumour model established from human glioblastoma biopsies. BMC Cancer (2009) 1.35
Stimulation of mucosal mast cell growth in normal and nude rat bone marrow cultures. Proc Natl Acad Sci U S A (1983) 1.32
Immunity to coccidiosis: T-lymphocyte- or B-lymphocyte-deficient animals. Infect Immun (1979) 1.23
In vivo models of primary brain tumors: pitfalls and perspectives. Neuro Oncol (2012) 1.21
The in vivo malignant transformation of mouse fibroblasts in the presence of human tumour xenografts. Br J Cancer (1986) 1.18
Metastasis in the nude rat associated with lack of immune response. Br J Cancer (1979) 1.13
Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS One (2011) 1.05
Balloon catheter de-endothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes. Am J Pathol (1991) 1.03
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival. Oncotarget (2013) 0.99
Dynamics of thymus organogenesis and colonization in early human development. Development (2013) 0.94
FOXN1: A Master Regulator Gene of Thymic Epithelial Development Program. Front Immunol (2013) 0.94
Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy. PLoS One (2014) 0.91
Human tumour xenografts in athymic rats and their age dependence. Br J Cancer (1982) 0.91
Periodontal bone loss and immune characteristics of congenitally athymic and thymus cell-reconstituted athymic rats. Infect Immun (1985) 0.89
Antibody-dependent cellular cytotoxicity (K) and natural killing (NK) in B-suppressed germ-free nude rats. Immunology (1983) 0.87
Growth of human digestive-tumour xenografts in athymic nude rats. Br J Cancer (1981) 0.85
Immunoglobulins of rnu/rnu 'nude' rats with congenital aplasia of the thymus. Immunology (1983) 0.85
Activation of rat B lymphocytes by Actinobacillus actinomycetemcomitans. Infect Immun (1985) 0.84
Immunoglobulin D in rat serum, saliva and milk. Immunology (1985) 0.84
Human fetal cerebellar and cortical tissue transplanted to the anterior eye chamber of athymic rats: electrophysiological and structural studies. Proc Natl Acad Sci U S A (1987) 0.82
Eosinophilia in athymic nude (rnu/rnu) rats--thymus-independent eosinophilia? Immunology (1981) 0.82
IgE receptors, IgE content and secretory response of mast cells in athymic rats. Immunology (1994) 0.82
T-cell receptor-bearing cells from athymic nude rats respond to alloantigen in vitro but are defective in vivo. Immunology (1991) 0.82
Progressive growth of a human pleural mesothelioma xenografted to athymic rats and mice. Br J Cancer (1988) 0.80
Models of abnormal scarring. Biomed Res Int (2013) 0.80
Effect of host immune status on the spontaneous metastasis of cloned cell lines of the 13762NF rat mammary adenocarcinoma. Br J Cancer (1985) 0.79
Antibody response of nude (RNU/RNU) and hairy (RNU/+) rats to circulating cell surface components from human pancreatic cancer xenografts. Br J Cancer (1983) 0.79
Reliable establishment of human sarcoma xenografts in the nude rat. Sarcoma (1999) 0.79
Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma. PLoS One (2014) 0.78
Immunoglobulin levels of congenitally athymic rats immunized with thymus-dependent-independent antigens. Immunology (1986) 0.75
A novel GFP nude rat model to investigate tumor-stroma interactions. Cancer Cell Int (2014) 0.75
Hair follicles of young Wistar strain hairless rats: a histological study. J Anat (1997) 0.75
The influence of the hair-follicle cycle on skin allografts in the congenitally athymic "nude" mouse. Br J Exp Pathol (1981) 0.75
The role of the thymus in the eosinophil response of rats infected with Fasciola hepatica. Clin Exp Immunol (1982) 0.75
T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis. BMC Neurosci (2015) 0.75
The sequence of the human genome. Science (2001) 101.55
Genealogies of mouse inbred strains. Nat Genet (2000) 8.06
Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA (2000) 4.49
The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04
Threshold of fragmentation for ultrasonic contrast agents. J Biomed Opt (2001) 2.39
Misleading response of malignant gastric ulcers to cimetidine. Lancet (1978) 2.25
Effects of methyl isocyanate on the respiratory tract of rats. Br J Ind Med (1985) 2.13
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis (2009) 1.71
Response to selection for body weight and egg weight in chickens. Genetics (1967) 1.69
Error rates in cervical cytological screening tests. Br J Cancer (1974) 1.61
Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics. Br J Cancer (1999) 1.56
Evolution and diversity of subduction zones controlled by slab width. Nature (2007) 1.54
The life-space diary: a measure of mobility in old people at home. Int Rehabil Med (1985) 1.54
Chemical trapping of a reactive metabolite. The metabolism of the AZO-mustard 2'-carboxy-4-di-(2-chloroethyl)amino-2-methylazobenzene. Biochem Pharmacol (1972) 1.38
Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells. Cancer Res (1974) 1.38
Studies on the immunobiology of rnu/rnu "nude" rats with congenital aplasia of the thymus. Eur J Immunol (1980) 1.36
New platinum complexes with anti-tumour activity. Chem Biol Interact (1972) 1.35
Posterior lumbar interbody fusion with cages: an independent review of 71 cases. J Neurosurg (1999) 1.34
Acid mucopolysaccharides in electron microscopy. The use of the colloidal iron method. J Anat (1965) 1.33
Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia (2006) 1.29
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem Pharmacol (1974) 1.29
A morphologic and histochemical study of metaplastic polyps of the colorectum. Cancer (1984) 1.24
Renal damage caused by gentamicin: a study of the effects on renal morphology and urinary enzyme excretion. J Pathol (1976) 1.24
Methyl isocyanate: thiosulphate does not protect. Lancet (1985) 1.24
Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. Am J Physiol (1986) 1.23
Tumour inhibitory triazenes: structural requirements for an active metabolite. Biochem Pharmacol (1976) 1.22
The in vivo malignant transformation of mouse fibroblasts in the presence of human tumour xenografts. Br J Cancer (1986) 1.18
Walker carcinosarcoma 256 in study of anticancer agents. I. Method for simultaneous assessment of therapeutic value and toxicity. Cancer Res (1966) 1.13
Cure of mice bearing advanced plasma cell tumours with aniline mustard: the relationship between glucuronidase activity and tumour sensitivity. Nature (1966) 1.12
In vitro studies with hexamethylmelamine. Biochem Pharmacol (1977) 1.12
Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol (1992) 1.12
In vivo studies with hexamethylmelamine. Eur J Cancer (1978) 1.11
Value of brush cytology in diagnosis of gastric cancer. Br Med J (1975) 1.09
Cutaneous manifestations in inflammatory bowel disease. Z Gastroenterol (2001) 1.08
Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene. Cancer Res (1997) 1.07
2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256. Biochem Pharmacol (1969) 1.06
Failure of nude (athymic) rats to become resistant to reinfection with the intestinal coccidian parasite Eimeria nieschulzi or the nematode Nippostrongylus brasiliensis. Parasite Immunol (1979) 1.04
Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res (1998) 1.03
Comparison of nitrogen-mustard sensitive and -resistant Yoshida sarcomas. Int J Cancer (1966) 1.03
Adaptive functioning and behaviour problems in relation to level of education in children and adolescents with intellectual disability. J Intellect Disabil Res (2005) 1.02
The comparative toxicology of ethyl- and methylmercury. Arch Toxicol (1985) 1.01
Protection against the toxicity of alkylating agents by thiols: the mechanism of protection and its relevance to cancer chemotherapy. A review. Eur J Cancer (1966) 1.01
Wheel activity in 26 strains of mouse. Lab Anim (1977) 1.00
Pleural effusion and a pelvic mass. Postgrad Med J (1998) 1.00
Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease. Cancer Immunol Immunother (1989) 0.99
The correlation of regression in primary melanoma with sentinel lymph node status. J Clin Pathol (2007) 0.99
Life span of specified-pathogen-free (MRC category 4) mice and rats. Lab Anim (1971) 0.98
Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. Arthritis Rheum (2007) 0.98
Atypical fibroxanthoma of the skin with metastasis. Cancer (1986) 0.98
Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex. Gastroenterology (1986) 0.96
Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the Walker tumour. Int J Cancer (1971) 0.96
Chemical accidents and toxicology. Hum Toxicol (1985) 0.96
Good and bad patients: a review of the literature and a theoretical critique. J Adv Nurs (1982) 0.96
Isolation and identification of a mucopolysaccharide from egg-white. Nature (1966) 0.96
An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (2001) 0.96
Whisker trimming in mice. Lab Anim (1981) 0.96
Evaluation of a patterning treatment for retarded children. Pediatrics (1978) 0.95
Mucopolysaccharides in peritoneal granulomas in the rat. J Pathol Bacteriol (1966) 0.94
An allelic difference determines reciprocal patterns of expression of binding sites for Dolichos biflorus lectin in inbred strains of mice. J Embryol Exp Morphol (1985) 0.93
Combination chemotherapy: the interaction of methotrexate and 5-fluorouracil. Eur J Cancer (1973) 0.93
Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Report for Children and their Parents. Arthritis Rheum (1991) 0.92
Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances. J Toxicol Environ Health (1996) 0.92
The effect of asparaginase on some animal-tumors. Recent Results Cancer Res (1970) 0.91
Mormon demographic history I. Nuptiality and fertility of once-married couples. Popul Stud (Camb) (1978) 0.91
The microbiological and parasitological status of laboratory animals from accredited breeders in the United Kingdom. Lab Anim (1976) 0.90
LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer (1997) 0.89
Studies on the mechanism of action of the tumour inhibitory triazenes. Biochem Pharmacol (1973) 0.89
Biochemical markers in inbred strains of the rat (Rattus norvegicus). Immunogenetics (1984) 0.89
Investigation of ranitidine 150 mg bd or 300 mg bd in the treatment of reflux disease. Hepatogastroenterology (1986) 0.89
Phenotypic variability of inbred and outbred mice. Nature (1976) 0.88
Alkylating agents. Top Curr Chem (1974) 0.88
The gene controlling the binding sites of Dolichos biflorus agglutinin, Dlb-1, is on chromosome 11 of the mouse. Genet Res (1986) 0.88
PGP9.5: a marker for cellular neurothekeoma. Am J Surg Pathol (1999) 0.87
Structure-activity relationships of the antitumor platinum coordination complexes. Cancer Treat Rep (1980) 0.87
Persistence of pneumonia virus of mice and Sendai virus in germ-free (nu/nu) mice. Br J Exp Pathol (1980) 0.86
Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev (2001) 0.86
The toxicity of merophan after pretreatment with subtoxic dose. Acta Physiol Acad Sci Hung (1968) 0.86
Meloidogyne incognita Resistance Characteristics in Tomato Genotypes Developed for Processing. J Nematol (1986) 0.86
PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination. Br J Cancer (2001) 0.86
DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation. Carcinogenesis (1995) 0.86
Biomechanical comparison of ankle arthrodesis techniques: crossed screws vs. blade plate. Foot Ankle Int (2001) 0.85
Lymphoid interstitial pneumonia in juvenile rheumatoid arthritis. J Pediatr (1984) 0.85
Effect of prolonged saline loading on HgCl2-induced renal tubular damage. Br J Exp Pathol (1984) 0.85
Antagonism of the anti-tumour effects of asparaginase by methotrexate. Biochem Pharmacol (1970) 0.85
Stimulation of pepsinogen release from isolated gastric glands by cholecystokininlike peptides. Am J Physiol (1983) 0.84
Cure of mice bearing advanced plasma cell tumours with aniline mustard. Nature (1965) 0.84
A gene location for the inheritance of the cataract Fraser (CatFr) mouse congenital cataract. Genet Res (1987) 0.84
A comparison in germ-free mice of the pathogenesis of Sendai virus and mouse pneumonia virus infections. J Pathol (1980) 0.84
Microsomal activation of cyclophosphamide in vivo. Biochem Pharmacol (1970) 0.84
Methylation of cysteine in hemoglobin following exposure to methylating agents. Cancer Res (1981) 0.84
Interaction of methotrexate and cytosine arabinoside. Lancet (1972) 0.84
Metastatic carcinoid tumour in association with small bowel ischaemia and infarction. J R Soc Med (1990) 0.84
Low levels of cryofibrinogenaemia and peripheral circulatory dysfunction. Ir Med J (1991) 0.83
Commentary: screening for anti-cancer agents; the relative merits of in vitro and in vovo techniques. Biochem Pharmacol (1975) 0.83
[Transthoracic transvertebral approach for resection of an anteriorly located, calcified meningioma. Case report]. Neurochirurgie (2002) 0.82
Cytology in the diagnosis of oesophageal cancer. Lancet (1976) 0.82
1-Naphthol: a potential selective antitumour agent. Biochem Pharmacol (1983) 0.82
Chemotherapy of human tumors in T-lymphocyte-deficient mice. Cancer Treat Rep (1977) 0.82
Structure and activity relationships of platinum complexes with anti-tumour activity. Chem Biol Interact (1975) 0.82